These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Fibers in lung tissues of mesothelioma cases among miners and millers of the township of Asbestos, Quebec. Dufresne A, Harrigan M, Massé S, Bégin R. Am J Ind Med; 1995 Apr; 27(4):581-92. PubMed ID: 7793429 [Abstract] [Full Text] [Related]
7. Deposition and retention of inhaled fibres: effects on incidence of lung cancer and mesothelioma. Lippmann M. Occup Environ Med; 1994 Dec 01; 51(12):793-8. PubMed ID: 7849861 [Abstract] [Full Text] [Related]
9. Asbestos use and carcinogenicity in Germany and a comparison with animal studies. Pott F. Ann Occup Hyg; 1994 Aug 01; 38(4):589-600, 420. PubMed ID: 7978982 [Abstract] [Full Text] [Related]
14. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans. Garabrant DH, Pastula ST. Toxicol Appl Pharmacol; 2018 Dec 15; 361():127-136. PubMed ID: 30077661 [Abstract] [Full Text] [Related]
15. Fiber exposure reassessed with the new indices. Schneider T, Skotte J. Environ Res; 1990 Feb 15; 51(1):108-16. PubMed ID: 2153537 [Abstract] [Full Text] [Related]
16. Mineralogy of asbestos. Sporn TA. Recent Results Cancer Res; 2011 Feb 15; 189():1-11. PubMed ID: 21479892 [Abstract] [Full Text] [Related]
19. Airborne fibre concentrations and lung burden compared to the tumour response in rats and humans exposed to asbestos. Rödelsperger K, Woitowitz HJ. Ann Occup Hyg; 1995 Oct 15; 39(5):715-25. PubMed ID: 8526402 [Abstract] [Full Text] [Related]